# The Vascular Effects of Carvedilol Controlled Release (CR) in Abdominally Obese Hypertensive Patients

> **NCT00459056** · PHASE3 · COMPLETED · sponsor: **St. Paul Heart Clinic** · enrollment: 25 (actual)

## Conditions studied

- Abdominal Obesity
- Hypertension

## Interventions

- **DRUG:** Carvedilol CR + Lisinopril
- **DRUG:** Lisinopril + HCTZ

## Key facts

- **NCT ID:** NCT00459056
- **Lead sponsor:** St. Paul Heart Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-04
- **Primary completion:** 2010-05
- **Final completion:** 2010-05
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2013-12-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00459056

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00459056, "The Vascular Effects of Carvedilol Controlled Release (CR) in Abdominally Obese Hypertensive Patients". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT00459056. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*